UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Tobam

Tobam increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 22.7% in the third quarter, Holdings Channel reports. The firm owned 2,320 shares of the healthcare conglomerate’s stock after purchasing an additional 429 shares during the quarter. Tobam’s holdings in UnitedHealth Group were worth $1,356,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Macroview Investment Management LLC boosted its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC grew its holdings in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at $31,000. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC lifted its holdings in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $597.68 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The business has a 50-day moving average of $582.98 and a 200-day moving average of $529.56. The firm has a market capitalization of $551.91 billion, a P/E ratio of 39.63, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the business posted $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group’s payout ratio is currently 55.70%.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on UNH shares. Argus upped their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Truist Financial lifted their target price on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. TD Cowen increased their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, HSBC upped their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.